CDK7-IN-12
CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43) [1].
Product Specifications
CAS Number
2750638-94-7
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk7-in-12.html
Solubility
10 mM in DMSO
Smiles
FC(C1=C(C2=CNC3=C2C=CC=C3)N=C(N[C@@H]4CNCCC4)C5=NC=CN51)(F)F
Molecular Formula
C20H19F3N6
Molecular Weight
400.40
References & Citations
[1]Jing Wang, et al. Heterocyclic compounds and their derivatives. Patent WO2021249417A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC400463 20 µg
Annexin VI (ANXA6) (NM_001155) Human Over-expression Lysate
Sign In for Pricing
View Details 
